Abbott Laboratories (ABT)
Return on assets (ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 13,402,000 | 5,723,000 | 6,933,000 | 7,071,000 | 4,495,000 |
| Total assets | US$ in thousands | 81,414,000 | 73,214,000 | 74,438,000 | 75,196,000 | 72,548,000 |
| ROA | 16.46% | 7.82% | 9.31% | 9.40% | 6.20% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $13,402,000K ÷ $81,414,000K
= 16.46%
Abbott Laboratories' Return on Assets (ROA) has shown a positive trend over the past five years, starting at 6.20% as of December 31, 2020, and increasing to 16.46% as of December 31, 2024. This improvement indicates that the company has become more efficient in generating profits relative to its total assets. The ROA figure for 2021 stood at 9.40%, demonstrating a significant uptick from the previous year. However, there was a slight dip in ROA in 2023 to 7.82% before rebounding in 2024. Overall, Abbott Laboratories' ROA performance reflects the company's ability to utilize its assets effectively to generate profits for its shareholders.
Peer comparison
Dec 31, 2024